Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A step forward for patients with NRAS-mutant melanoma.

The Lancet. Oncology - 1 Apr 2017

Postow Michael A, Chapman Paul B

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to NRAS gene
Share to GTP Phosphohydrolases
Share to Melanoma
Share to Membrane Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 28284558
DOI: 10.1016/S1470-2045(17)30172-9
PMCID: PMC5540131

Genes

NRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A step forward for patients with NRAS-mutant melanoma.PMID 28284558Read ↗

Targeting NRAS Mutations in Advanced Melanoma.Semantic proximity Read ↗

Current Perspectives and Novel Strategies of NRAS-Mutant MelanomaSemantic proximity Read ↗

NRAS mutant melanoma: Towards better therapies.Semantic proximity Read ↗

NRAS-mutant melanoma: response to chemotherapy.Semantic proximity Read ↗

Targeting mutant NRAS signaling pathways in melanoma.Semantic proximity Read ↗

<em>NRAS</em>-mutant melanoma: current challenges and future prospectSemantic proximity Read ↗

Beyond BRAF: where next for melanoma therapy?Semantic proximity Read ↗

Targeting the MAPK pathway for NRAS mutant melanoma: from mechanism to clinic.Semantic proximity Read ↗

NRAS mutant melanoma: biological behavior and future strategies for therapeutic management.Semantic proximity Read ↗

[Guidelines for stage I to III melanoma].Semantic proximity Read ↗

BRAF, NRAS and C-KIT Advanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and Survival.Semantic proximity Read ↗

BRAF and NRAS mutations in Russian melanoma patients: results of a nationwide study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.